TY  - JOUR 
AU  - Fernández Montes, Ana
AU  - Martinez Lago, Nieves Purificacion
AU  - Covela Rúa, Marta
AU  - De La Cámara Gómez, Juan Cruz
AU  - González Villaroel, Paula
AU  - Méndez Méndez, José Carlos
AU  - Jorge Fernández, Monica
AU  - Salgado Fernández, Mercedes
AU  - Reboredo Lopez, Margarita
AU  - Quintero Aldana, Guillermo
AU  - Pellón Augusto, María Luz
AU  - Graña Suárez, Begoña
AU  - García. Gómez, Jesús
PY  - 2019
SN  - 2045-7634
UR  - http://hdl.handle.net/20.500.11940/15807
AB  - PURPOSE: The phase III VELOUR trial demonstrated efficacy with combined FOLFIRI-aflibercept in patients with metastatic colorectal cancer previously treated with oxaliplatin with or without bevacizumab versus placebo. The effect of FOLFIRI-aflibercept...
LA  - eng
KW  - Adult
KW  - Middle Aged
KW  - Fluorouracil
KW  - Survival Rate
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Humans
KW  - Treatment Outcome
KW  - Camptothecin
KW  - Recombinant Fusion Proteins
KW  - Leucovorin
KW  - Liver Neoplasms
KW  - Aged
KW  - Retrospective Studies
KW  - Colorectal Neoplasms
TI  - Efficacy and safety of FOLFIRI/aflibercept in second-line treatment of metastatic colorectal cancer in a real-world population: Prognostic and predictive markers
DO  - 10.1002/cam4.1903
T2  - Cancer Medicine
M2  - 882
KW  - CHUF
KW  - CHUAC
KW  - CHUO
KW  - CHUVI
KW  - HULA
VL  - 8
ER  -